arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Axsome Therapeutics, Inc.

AXSM Health Care Biotechnology: Pharmaceutical Preparations
$206.68
Today
as of Sep 4, 16:46 ET
Last 30 days -11.75% Jul 28 → Sep 04
$195.63 $206.11 $216.58 $227.05 $237.53 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$207.01
High
$208.51
Low
$205.49
Volume
$438,239
Avg Vol
$685,184
Mkt Cap
$11.2B
P/E (TTM)
—
Beta
—
52w High
$260.19
52w Low
$112.90
Div Yield
—
Shares Out
$52M

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 07:59 MT Newswires
Axsome Therapeutics Insider Sold Shares Worth $2,086,500, According to a Recent SEC Filing
Sep 2 · 11:00 PR GlobeNewswire
Axsome Therapeutics to Participate in Upcoming Investor Conferences
Sep 1 · 16:05 Zacks
Axsome Begins Phase III Study on AXS-05 for Smoking Cessation
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$113
$260
64% of range
Avg surprise (last 3)
-1.2%
Avg reaction (last 2)
+6.1%
100% positive
Latest IV / EM
38%
EM ±5.9% · $210 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.67$-1.00$-0.33$0.33$1.00 Actual $-0.26Actual $-1.54Actual $-1.32Actual $-1.44Actual $-1.67Actual $-1.34Actual $-0.80Est $-1.26Actual $-0.92Est $1.00Actual $-0.94Actual $-1.26Est $-0.85Actual $-0.99 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-65M$9M$82M$156M$229M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.99 — — — — financials
Mon May 4, 2026Mar/2026 $-1.26 $-0.85 -48.2% -57.5% +8.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.94 — — — — financials
Mon Aug 4, 2025Jun/2025 $-0.92 $1.00 +8.0% — — earnings
Mon May 5, 2025Mar/2025 $-0.80 $-1.26 +36.5% — +3.8% earnings
Mon Sep 30, 2024Sep 2024 $-1.34 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.67 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.44 — — — — financials
Sat Sep 30, 2023Sep 2023 $-1.32 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.54 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.26 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$218M$191M—$171M$150M$121M—$105M
Cost of revenue————————
Gross profit————————
Operating income$-50M$-63M—$-46M$-37M$-57M—$-63M
Net income$-51M$-65M—$-47M$-48M$-59M—$-65M
EPS (diluted)$-0.99$-1.26—$-0.94$-0.97$-1.22—$-1.34

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$320M$305M$323M$325M$303M$301M$315M$327M
Inventory$38M$32M$28M$24M$18M$16M$16M$14M
Total current assets$657M$611M$589M$565M$537M$495M$485M$479M
Total assets$761M$714M$690M$669M$640M$597M$568M$561M
Long-term debt$118M$118M$118M$118M$118M$181M$181M$180M
Total liabilities$678M$659M$602M$596M$567M$543M$511M$469M
Total equity$83M$55M$88M$74M$73M$53M$57M$93M

Implied volatility — last 90 days

36%44%51%59%67% Jun 07 — IV 42% · EM ±5.9%Jun 08 — IV 50% · EM ±6.5%Jun 09 — IV 46% · EM ±5.8%Jun 10 — IV 49% · EM ±5.8%Jun 11 — IV 46% · EM ±5.0%Jun 12 — IV 43% · EM ±4.4%Jun 15 — IV 46% · EM ±3.3%Jun 16 — IV 53% · EM ±3.2%Jun 17 — IV 59% · EM ±2.4%Jun 19 — IV 38% · EM ±8.4%Jun 22 — IV 39% · EM ±8.2%Jun 23 — IV 40% · EM ±8.1%Jun 24 — IV 38% · EM ±7.6%Jun 25 — IV 40% · EM ±7.9%Jun 26 — IV 40% · EM ±7.7%Jun 29 — IV 42% · EM ±7.5%Jun 30 — IV 40% · EM ±6.9%Jul 01 — IV 39% · EM ±6.6%Jul 02 — IV 43% · EM ±6.9%Jul 03 — IV 44% · EM ±6.9%Jul 06 — IV 47% · EM ±6.5%Jul 07 — IV 42% · EM ±5.6%Jul 08 — IV 42% · EM ±5.3%Jul 09 — IV 42% · EM ±5.0%Jul 10 — IV 38% · EM ±4.2%Jul 13 — IV 47% · EM ±3.9%Jul 14 — IV 49% · EM ±3.5%Jul 15 — IV 47% · EM ±2.8%Jul 16 — IV 67% · EM ±2.8%Jul 20 — IV 48% · EM ±11.2%Jul 21 — IV 49% · EM ±11.4%Jul 22 — IV 49% · EM ±11.1%Jul 23 — IV 49% · EM ±11.1%Jul 24 — IV 49% · EM ±10.8%Jul 27 — IV 51% · EM ±10.6%Jul 28 — IV 51% · EM ±10.4%Jul 29 — IV 52% · EM ±10.5%Jul 30 — IV 50% · EM ±9.8%Jul 31 — IV 53% · EM ±10.1%Aug 03 — IV 63% · EM ±11.2%Aug 04 — IV 63% · EM ±10.9%Aug 05 — IV 60% · EM ±10.1%Aug 06 — IV 64% · EM ±10.4%Aug 07 — IV 68% · EM ±10.6%Aug 10 — IV 44% · EM ±6.1%Aug 11 — IV 46% · EM ±6.1%Aug 12 — IV 46% · EM ±5.8%Aug 13 — IV 41% · EM ±4.8%Aug 14 — IV 37% · EM ±4.1%Aug 17 — IV 50% · EM ±4.2%Aug 18 — IV 47% · EM ±3.4%Aug 19 — IV 50% · EM ±3.0%Aug 20 — IV 58% · EM ±2.4%Aug 24 — IV 40% · EM ±8.4%Aug 25 — IV 39% · EM ±8.0%Aug 26 — IV 40% · EM ±8.0%Aug 27 — IV 38% · EM ±7.5%Aug 28 — IV 36% · EM ±6.9%Aug 31 — IV 39% · EM ±6.8%Sep 01 — IV 40% · EM ±6.8%Sep 02 — IV 38% · EM ±6.3%Sep 03 — IV 39% · EM ±6.4%Sep 04 — IV 38% · EM ±5.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in